-
Je něco špatně v tomto záznamu ?
Does inhibition of aldose reductase contribute to the anti-inflammatory action of setipiprant
J. Ballekova, M. Soltesova-Prnova, M. Majekova, M. Stefek
Jazyk angličtina Země Česko
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 1991
Free Medical Journals
od 1998
ProQuest Central
od 2005-01-01
Medline Complete (EBSCOhost)
od 2006-01-01
Nursing & Allied Health Database (ProQuest)
od 2005-01-01
Health & Medicine (ProQuest)
od 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
od 1998
- MeSH
- aldehydreduktasa antagonisté a inhibitory metabolismus MeSH
- antiflogistika chemie farmakologie MeSH
- indoly chemie farmakologie MeSH
- inhibitory enzymů metabolismus farmakologie MeSH
- krysa rodu rattus MeSH
- lidé MeSH
- NADP metabolismus MeSH
- naftaleny chemie farmakologie MeSH
- potkani Wistar MeSH
- simulace molekulového dockingu metody MeSH
- vazebná místa fyziologie MeSH
- zvířata MeSH
- Check Tag
- krysa rodu rattus MeSH
- lidé MeSH
- mužské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
The aim of this study was to investigate aldose reductase inhibitory action of setipiprant as a potential additional mechanism contributing to its anti-inflammatory action. Aldose reductase activity was determined by spectrophotometric measuring of NADPH consumption. Setipiprant was found to inhibit aldose reductase/NADPH-mediated reduction of 4-hydroxynonenal, 4-hydroxynonenal glutathione and prostaglandin H2 substrates, all relevant to the process of inflammation. Molecular modeling simulations into the aldose reductase inhibitor binding site revealed an interaction pattern of setipiprant. Considering multifactorial etiology of inflammatory pathologies, it is suggested that, in addition to the antagonizing prostaglandin D2 receptor, inhibition of aldose reductase may contribute to the reported anti-inflammatory action of setipiprant.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18021067
- 003
- CZ-PrNML
- 005
- 20180621135909.0
- 007
- ta
- 008
- 180611s2017 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.33549/physiolres.933516 $2 doi
- 035 __
- $a (PubMed)28406694
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Ballekova, J $u Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Bratislava, Slovak Republic
- 245 10
- $a Does inhibition of aldose reductase contribute to the anti-inflammatory action of setipiprant / $c J. Ballekova, M. Soltesova-Prnova, M. Majekova, M. Stefek
- 520 9_
- $a The aim of this study was to investigate aldose reductase inhibitory action of setipiprant as a potential additional mechanism contributing to its anti-inflammatory action. Aldose reductase activity was determined by spectrophotometric measuring of NADPH consumption. Setipiprant was found to inhibit aldose reductase/NADPH-mediated reduction of 4-hydroxynonenal, 4-hydroxynonenal glutathione and prostaglandin H2 substrates, all relevant to the process of inflammation. Molecular modeling simulations into the aldose reductase inhibitor binding site revealed an interaction pattern of setipiprant. Considering multifactorial etiology of inflammatory pathologies, it is suggested that, in addition to the antagonizing prostaglandin D2 receptor, inhibition of aldose reductase may contribute to the reported anti-inflammatory action of setipiprant.
- 650 _2
- $a aldehydreduktasa $x antagonisté a inhibitory $x metabolismus $7 D000449
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a antiflogistika $x chemie $x farmakologie $7 D000893
- 650 _2
- $a vazebná místa $x fyziologie $7 D001665
- 650 _2
- $a inhibitory enzymů $x metabolismus $x farmakologie $7 D004791
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a indoly $x chemie $x farmakologie $7 D007211
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a simulace molekulového dockingu $x metody $7 D062105
- 650 _2
- $a NADP $x metabolismus $7 D009249
- 650 _2
- $a naftaleny $x chemie $x farmakologie $7 D009281
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani Wistar $7 D017208
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Soltesova-Prnova, M. $u Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Bratislava, Slovak Republic
- 700 1_
- $a Májeková, Magdaléna $7 xx0156565 $u Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Bratislava, Slovak Republic
- 700 1_
- $a Štefek, Milan $7 xx0246327 $u Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Bratislava, Slovak Republic
- 773 0_
- $w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 66, č. 4 (2017), s. 687-693
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28406694 $y Pubmed
- 910 __
- $a ABA008 $b A 4120 $c 266 $y 4 $z 0
- 990 __
- $a 20180611 $b ABA008
- 991 __
- $a 20180619130018 $b ABA008
- 999 __
- $a ok $b bmc $g 1311781 $s 1017939
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 66 $c 4 $d 687-693 $e 20170412 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
- LZP __
- $b NLK118 $a Pubmed-20180611
